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Prevalence and Risk Factors Associated With Long-term Opioid Use
After Injury Among Previously Opioid-Free Workers
Zoe Durand, PhD; Sarah Nechuta, PhD; Shanthi Krishnaswami, MBBS, MPH; Eric L. Hurwitz, PhD; Melissa McPheeters, PhD

Abstract
IMPORTANCE Using opioids for acute pain can lead to long-term use and associated morbidity and
mortality. Injury has been documented as a gateway to long-term opioid use in some populations,
but data are limited for injured workers.
OBJECTIVE To evaluate the prevalence and risk factors of long-term opioid use after injury among
workers in Tennessee who were opioid free at the time of injury.

Key Points
Question What is the prevalence of
long-term opioid use after injury among
previously opioid-free workers in
Tennessee, and what risk factors are
associated with developing long-term
opioid use after injury?
Findings In this cohort study of 46 399

DESIGN, SETTING, AND PARTICIPANTS This cohort study identified injured workers aged 15 to 99

injured workers who were opioid free

years who reported only 1 injury to the Tennessee Bureau of Workers’ Compensation from March

at the time of injury, 4.0% had long-term

2013 to December 2015 and had no opioid prescription in the 60 days before injury. Participants

opioid use after injury. Long-term use

were matched to their prescription history in Tennessee’s prescription drug monitoring program.

was associated with receiving 20 or

Analysis was conducted from November 2017 to March 2018. Logistic regression models were used

more days’ supply in the initial opioid

to calculate adjusted odds ratios (ORs) and 95% CIs for associations of demographic, injury, and

prescription and visiting 3 or more

opioid use variables with long-term use.

prescribers.
Meaning Prescribing characteristics

MAIN OUTCOMES AND MEASURES The primary outcome was long-term opioid use, defined as
having an opioid supplied for 45 or more days in the 90 days after injury.
RESULTS Among 58 278 injured workers who received opioids after injury (18 977 [32.5%] aged
15-34 years, 27 514 [47.2%] aged 35-54 years, and 11 787 [20.2%] aged 55-99 years; 32 607 [56.0%]
men), 46 399 (79.6%) were opioid free at the time of injury. Among opioid-free injured workers,
1843 (4.0%) began long-term opioid use. After controlling for covariates, long-term use was

were the strongest risk factors for longterm opioid use after injury.

+ Supplemental content
Author affiliations and article information are
listed at the end of this article.

associated with receiving 20 or more days’ supply in the initial opioid prescription compared with
receiving less than 5 days’ supply (OR, 28.94; 95% CI, 23.44-35.72) and visiting 3 or more prescribers
in the 90 days after injury compared with visiting 1 prescriber (OR, 14.91; 95% CI, 12.15-18.29).
However, even just 5 days’ to 9 days’ supply was associated with an increase in the odds of long-term
use compared with less than 5 days’ supply (OR, 1.83; 95% CI, 1.56-2.14).
CONCLUSIONS AND RELEVANCE In this study of injured workers, injury was associated with longterm opioid use. The number of days’ supply of the initial opioid prescription was the strongest risk
factor of developing long-term use, highlighting the importance of careful prescribing for initial
opioid prescriptions.
JAMA Network Open. 2019;2(7):e197222. doi:10.1001/jamanetworkopen.2019.7222
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Introduction
Long-term opioid use is about more than the number of days someone takes an opioid; it is also
about the threshold at which the costs of opioid use begin to outweigh the advantages. Research on
long-term opioid use for chronic pain was summarized in a systematic review of clinical trials and
observational studies,1 which reported no evidence of effectiveness for opioid use of greater than 3
months but increased risk of harms, including overdose, substance use disorder, fractures, and
myocardial infarction. An epidemiological study2 showed that long-term opioid use is associated with
dependence, addiction, poor self-rated health, inactivity, unemployment, higher health care
utilization, and poor self-rated quality of life. In injured workers specifically, long-term opioid therapy
is associated with higher health care costs3 and lower productivity.4
A 2018 study of workers’ compensation (WC) claimants in Maryland5 examined factors
associated with opioid use more than 90 days after injury, focusing on patient characteristics.
Associations with opioid use after 90 days were found for older age (ⱖ60 years vs 15-29 years: odds
ratio [OR], 1.92; 95% CI, 1.56-2.36), higher annual income (ⱖ$60 000 vs <$20 000: OR, 1.31; 95%
CI, 1.07-1.61), crush injuries vs soft-tissue or contusion injuries (OR, 1.55; 95% CI, 1.28-1.89), strains
and sprains vs soft-tissue or contusion injuries (OR, 1.54; 95% CI, 1.36-1.75), and chronic joint pain
(OR, 1.98, 95% CI 1.79-2.20).5
A 2017 study of a commercially insured population6 pointed to the number of days’ supply of
the initial prescription as the single largest factor in continued opioid therapy for more than 1 year and
more than 2 years after age, sex, mental comorbidities, and dose were controlled for. A retrospective
cohort study conducted in Oregon using prescription drug monitoring program data7 similarly
reported strong associations of dose (400-799 morphine milligram equivalents [MME] vs <120 MME
in a month: OR, 2.96; 95% CI, 2.81-3.11) and number of prescriptions filled (2 fills/mo vs 1 fill/mo: OR,
2.25; 95% CI, 2.17-2.33) with risk of long-term use of opioids (defined as ⱖ6 fills/y after initiation)
among previously opioid-free patients. Another study in Utah8 found increased odds of long-term
opioid use (defined as ⱖ120 prescription days or ⱖ90 prescription days with ⱖ10 fills in a year) in
patients who received benzodiazepines in the first 14 days of care (OR, 1.87; 95% CI, 1.01-3.48).
Among injured workers with back injuries, higher dose in the first 3 months after injury has been
shown to be associated with long-term opioid use even after baseline pain and injury severity are
controlled for (900-1799 MME vs ⱕ899 MME in first 3 months after injury: OR, 4.01; 95% CI,
2.23-7.20).9
Following the US Centers for Disease Control and Prevention guidelines, providing the lowest
dose of a short-acting opioid analgesic for the fewest days possible (preferably 3 and no more than 7
days) when opioids are initiated may mitigate the risk of developing long-term use10; however, data
are limited on the association of prescription-based factors, such as days’ supply and dose, with longterm use among injured workers. This cohort study was conducted to develop a predictive model for
the development of long-term opioid use in previously opioid-free injured workers. Demographic
and prescribing characteristics hypothesized to be factors associated with long-term use were
examined in previously opioid-free injured workers using Tennessee’s Controlled Substances
Monitoring Database (CSMD).

Methods
This study was approved by the institutional review boards at the Tennessee Department of Health
and University of Hawaii and follows the Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) reporting guideline for cohort studies.11 This study had no contact with
participants and was exempt from collecting informed consent.
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Study Design and Population
A detailed description of cohort creation was previously published.12 Briefly, data on workplace
injuries from Tennessee WC were linked to prescription records in the CSMD. Injured worker data
were obtained from WC records (First Report of Injury, shared by the Tennessee Department of
Labor), which is required regardless of the employee’s intention to pursue medical care or a WC
claim.13 The CSMD contains data on prescriptions for controlled substances that are filled, and
Tennessee dispensers are generally required to report filled prescriptions within 1 business day, with
the exception of veterinarians, who were excluded from this study.14
Data cleaning (eg, correcting errors and standardizing fields to enable linkage and analysis) and
linkage between data sources on name and date of birth has been previously described.12 To allow
for prescriptions to be measured from 60 days prior to injury through 180 days after injury,
prescription records were accessed from January 1, 2013, to June 30, 2016, and WC records were
accessed from March 2, 2013, to December 31, 2015. Analysis was conducted from November 2017
to March 2018.
The main study population was opioid free at the time of injury, defined as having no record of
receiving an opioid prescription for 60 days before the injury.15 Opioid dispensing in Tennessee is
limited to 30 days’ supply,16 and a 60-day restriction allows for only 2 consecutive periods of 30-day
prescriptions. No injured workers receiving opioids for medication-assisted treatment were included
in the study. Eligibility required complete name and date of birth data in the WC record to enable
matching to the CSMD, having sex data, having a physical injury, and being aged 15 to 99 years. To
avoid the confounding effect of multiple injuries, eligibility was restricted to injured workers who
reported only 1 injury during the study period. Opioid prescriptions were included if they were opioid
class and schedule 2 to 4 (schedule 5 was excluded owing to very low dose, eg, cough syrups) and
excluded if they were known to be dispensed by a veterinarian or Veterans Affairs pharmacy.
Veterans Affairs pharmacies had incomplete reporting, composed a low amount (1%) of all opioid
prescriptions, and were excluded owing to concerns regarding missing data. Prescription criteria
resulted in only prescriptions being excluded, not patients. Opioid prescriptions were measured from
60 days before each person’s date of injury (earliest January 1, 2013) to 180 days after each person’s
injury (latest June 30, 2016).

Demographic Characteristics and Clinical Information
Age at the time of injury, sex, marital status, type of injury, part of body injured, and residence type
were selected from WC records on the basis of availability, completeness, and previous
literature.7,17,18 Type of injury was categorized into strains, sprains, and tears; fractures; and other on
the basis of frequency and hypothesized association with long-term opioid use. Part of body injured
was categorized into lower back, finger(s), knee, and other on the basis of frequency and association
with long-term use. Additional clinical data were not available. Residence type was identified from
zip codes and classified as urban (residing in a county with one of Tennessee’s 6 largest cities) or rural
(residing in one of the other 89 counties).
Postinjury opioids were classified by type, formulation (short-acting or long-acting), payment
(cash or other), and overlapping days with a benzodiazepine prescription. Maximum daily dose in
MME and maximum days’ supply were identified. Each prescription measure, including dose and
days’ supply, was completed for 7 days, 30 days, and 90 days after injury. Additional prescription
characteristics included dose and days’ supply of the first prescription, receiving benzodiazepine in
the 60 days before the injury, and the number of prescribers and pharmacies visited during the 90
days after the injury. For workers who received multiple opioid prescriptions on the same day (1695
[2.9%]), MME and days’ supply were summed for all eligible opioid prescriptions received on
that day.
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Primary Outcome
Long-term opioid analgesic use, the primary study outcome, was measured with prescription days,
ie, the days’ supply of an opioid prescription added to the date on which the opioid was received. For
overlapping prescriptions, prescription days were only counted once. Corresponding to the Centers
for Disease Control and Prevention definition of chronic pain as lasting longer than 3 months,19 longterm use was defined as receiving an opioid on most days for a 90-day period, measured as 45 or
more prescription days in 90 days after injury. Nonoverlapping prescription days were summed for
all prescriptions that were received and did not need to be continuous.

Statistical Analysis
A split data set approach20 was used for model building. The sample of opioid-free injured workers
whose injuries occurred in 2013 and 2014 (n = 30 608) was used for the derivation model, and those
with injuries in 2015 (n = 15 791) were used for validating the derivation model. Numbers and
percentages were used to describe the distribution of demographic and clinical characteristics in the
population by opioid-free status.
To visualize the arc of opioid use over time, the number of injured workers who received opioids
on most days was calculated by 30-day periods from 0 to 180 days after injury and graphed. To
identify associations with long-term opioid use, unconditional logistic regression was used to
compute unadjusted and adjusted ORs with 95% CIs for the binary outcome.
To build the derivation model, demographic and clinical variables that showed an association
with long-term use in unadjusted models were selected for inclusion in a multivariable model. Where
different time frames had been considered for opioid-use measures (eg, long-acting opioid received
within 7 days vs 30 days vs 90 days of injury), the time frame with the highest associated point
estimate was included in the starting multivariable model. The multivariable model was then refined
with feedback from receiver operating characteristic curve C statistics,21 systematically changing
variables and time frames to maximize model discrimination. Model fit was assessed based on
deviance statistics, Pearson statistics, and Hosmer-Lemeshow statistics. After the best-fitting
derivation model had been achieved, the model parameters were applied to the validation group to
form the validation model, and the validation model fit and associations were compared with the
derivation model. SAS version 9.4 (SAS Institute) was used for all analyses. P < .05 was considered
statistically significant, and all tests were 2-tailed.

Results
Demographic Characteristics and Opioid-Free Status
Of 205 565 injured workers who reported 1 injury to Tennessee WC, 128 885 met eligibility criteria,
and 58 278 received opioids in the 90 days after injury (18 977 [32.5%] aged 15-34 years, 27 514
[47.2%] aged 35-54 years, and 11 787 [20.2%] aged 55-99 years; 32 607 [56.0%] men). Among
injured workers who received opioids, 46 399 (79.6%) were opioid free at the time of injury (Figure 1
and Table 1). Most (38 080 [82.1%]) received their first opioid prescription within a month of injury,
but 8319 (17.9%) received their first opioid prescription later. Overall, 1834 (4.0%) of those who
received opioids began long-term use. Sustained opioid use (ie, received an opioid on most days for
every 30-day period up to 90 days after injury) was found in 653 patients (1.7%). The highest dose
received in the first prescription by an opioid-free patient was 770 MME.
Injured workers who started using opioids late (received first opioid prescription 31-90 days
after injury) had a similar age distribution as those who started using opioids early (received first
opioid within 30 days of injury) but were significantly more likely to be female (15 460 [48.9%] vs
4066 [40.6%]) and have back injuries (4760 [12.5%] vs 773 [9.3%]) and were less likely to have
fractures (914 [2.0%] vs 915 [11.0%]). Compared with injured workers with a recent history of opioid
use, opioid-free injured workers in the derivation model were significantly more likely to be younger
than 35 years (10 663 [34.8%] vs 1925 [24.0%]), male (17 687 [57.8%] vs 3921 [48.8%]), have a
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fracture (2755 [9.0%] vs 439 [5.5%]), have a finger injury (3118 [10.2%] vs 603 [7.5%]), and be from
urban areas (11 681 [38.2%] vs 2548 [31.7%]) (Table 2). The population used for the validation model
showed similar distributions.

Long-term Opioid Use
The number of injured workers who received an opioid on most days decreased sharply from 1834 to
966 between the first and second month after injury and decreased less steeply between 31 and 120
days after injury. The number plateaued after 120 days (Figure 2).
Derivation Model Analyses
In unadjusted analyses of the derivation group (Table 3), long-term opioid use was associated with
receiving 20 or more days’ supply in the initial prescription compared with less than 5 days’ supply
(OR, 14.00; 95% CI, 11.89-16.48), visiting 3 or more prescribers compared with visiting 1 (OR, 22.76;
95% CI, 19.55-26.51), and visiting 3 or more pharmacies compared with visiting 1 (OR, 18.82; 95% CI,
16.00-22.15). In the multivariable predictive model (see Table 3 for covariates), long-term opioid use
continued to be associated with receiving 20 or more days’ supply in the initial prescription
compared with less than 5 days’ supply (OR, 28.94; 95% CI, 23.44-35.72), and even 5 days’ to 9 days’
supply was associated with an increase in the odds of long-term use compared with less than 5 days’
supply (OR, 1.83; 95% CI, 1.56-2.14). Visiting 3 or more prescribers, compared with visiting 1, also
continued to be associated with long-term opioid use (OR, 14.91; 95% CI, 12.15-18.29). Adding the
number of prescribers visited to the model decreased the association of long-term opioid use with
the number of pharmacies visited. Lower odds of long-term opioid use were found in finger injuries

Figure 1. Flowchart of Opioid Receipt and Use After Injury Among Previously Opioid-Free Workers
112 313 Workers injured from 2013 to 2015
and opioid-free at time of injury

46 399 Received opioid prescription within
90 d of injury

65 914 Did not receive opioid prescription
within 90 d of injury

38 080 Received first opioid prescription
within 30 d of injury

8319 Received first opioid prescription
31-90 d after injury

1702 Met definition of long-term use

132 Met definition of long-term use

653 Had sustained opioid use for 90 d
after injury

Long-term use was defined as having an opioid
supplied for 45 or more days in the 90 days after
injury. Sustained use was defined as having received
opioids on most days in all 30-day periods after injury
(ie, 0-30 days, 31-60 days, and 61-90 days).

Table 1. Sample Selection Method and Description of Sample Size
No.
Derivation Model (March 2,
2013-December 31, 2014)

Validation Model (January 1,
2015-December 31, 2015)

Reported only 1 physical injury to Tennessee
Workers’ Compensation, 2013-2015

133 309

72 256

Able to be linked to prescription history
(not missing name, sex, or date of birth)

132 299

71 836

Aged 15-99 y

131 882

71 672

Resided in Tennessee

83 853

45 032

Received an opioid within 90 d of injury

38 646

19 632

Opioid free at time of injury and included in
analysis

30 608

15 791

Study Selection Criteria
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compared with other body parts (OR, 0.62; 95% CI, 0.46-0.84). Higher odds were found in rural
residence compared with urban residence (OR, 1.51; 95% CI, 1.31-1.73), receiving a long-acting opioid
within 30 days of injury compared with receiving only short-acting opioids (OR, 3.01; 95% CI,
2.16-4.20), receiving overlapping opioid and benzodiazepine prescriptions within 30 days of injury

Table 2. Demographic and Clinical Characteristics of 58 278 Injured Workers Who Reported 1 Injury
to Tennessee Workers’ Compensation From March 2, 2013, to December 31, 2015, and Received Opioids
Within 90 Days of Injury, by Opioid-Free Status at Time of Injury
Opioid Free, No. (%)
Derivation Model
Characteristic

Validation Model

No (n = 8038)

Yes (n = 30 608)

No (n = 3841)

Yes (n = 15 791)

15-34

1925 (24.0)

10 663 (34.8)

839 (21.8)

5550 (35.2)

35-54

4278 (53.2)

14 121 (46.1)

2041 (53.1)

7074 (44.8)

55-99

1835 (22.8)

5824 (19.0)

961 (25.0)

3167 (20.1)

Male

3921 (48.8)

17 687 (57.8)

1826 (47.5)

9173 (58.1)

Female

4117 (51.2)

12 921 (42.2)

2015 (52.5)

6618 (41.9)

Single

188 (2.3)

694 (2.3)

88 (2.3)

303 (1.9)

Married

2403 (29.9)

8749 (28.6)

1079 (28.1)

4240 (26.9)

Age, y

Sex

Marital status

Widowed, separated, or divorced

1796 (22.3)

6561 (21.4)

1012 (26.4)

3841 (24.3)

Missing/unknown

3651 (45.4)

14 604 (47.7)

1662 (43.3)

7407 (46.9)

Type of injury
Strain, sprain, or tear

3193 (39.7)

11 994 (39.2)

1480 (38.5)

5839 (37.0)

Fracture

439 (5.5)

2755 (9.0)

214 (5.6)

1596 (10.1)

Other

4406 (54.8)

15 859 (51.8)

2147 (55.9)

8356 (52.9)

Lower back

965 (12.0)

3723 (12.2)

458 (11.9)

1791 (11.3)

Finger(s)

603 (7.5)

3118 (10.2)

279 (7.3)

1524 (9.7)

Other

6470 (80.5)

23 767 (77.7)

3104 (80.8)

12 476 (79.0)

Part of body injured

Residence type
Rural

5490 (68.3)

18 927 (61.8)

2627 (68.4)

9847 (62.4)

Urban

2548 (31.7)

11 681 (38.2)

1214 (31.6)

5944 (37.6)

East

2997 (37.3)

10 845 (35.4)

1410 (36.7)

5470 (34.6)

Middle

3420 (42.6)

12 425 (40.6)

1668 (43.4)

6463 (40.9)

West

1621 (20.2)

7338 (24.0)

763 (19.9)

3858 (24.4)

Geographical residence area in Tennessee

Figure 2. Number of Injured Workers Receiving Opioids Most Days for 180 Days After Injury
2000

Injured Workers Receiving Opioids
Most Days, No.

1800
1600
1400
1200
1000
800
600
400
200
0
0-30

31-60

61-90

91-120

121-150

151-180

Time After Injury, d
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(OR, 1.38; 95% CI, 1.10-1.72), visiting 3 or more pharmacies for opioids compared with visiting 1
pharmacy (OR, 4.54; 95% CI, 3.70-5.56), and receiving 160 or more daily MME within 30 days of
injury compared with less than 40 MME (OR, 3.24; 95% CI, 2.12-4.95) (Table 3). Receiving a longacting opioid contributed to better model discrimination than comparing specific opioid formulations
(C statistic, 0.92 vs 0.91).
Derivation and Validation Model Fit
The derivation model and validation model found similar associations for all variables, but the
validation model did not have a significant association of overlapping opioid and benzodiazepine
prescriptions with long-term opioid use (eTable 1 in the Supplement). Models had good
discrimination, with C statistics from receiver operating characteristic curves of 0.92 in the derivation
model and 0.91 in the validation model (eFigure 1 and eFigure 2 in the Supplement). Deviance
statistics for the derivation (1194.77) and validation (652.47) models were significant at low P values,
indicating a good fit (P = .001 and P = .009, respectively). Pearson statistics (1687.68 and 1067.39,
respectively) were significant at P < .001, indicating good fit, and Hosmer-Lemeshow statistics
(108.57 and 49.35, respectively) were significant, indicating good fit. When the number of
prescribers and pharmacies visited were removed from the derivation model, discrimination
decreased from a C statistic of 0.92 to 0.80. Associations were similar to the model with prescribers

Table 3. Associations of Demographic, Injury, and Opioid Use Variables With Long-term Opioid Use After Injury
in 30 608 Injured Workers Who Reported 1 Injury to Tennessee Workers’ Compensation and Were Opioid Free
at Time of Injurya,b
OR (95% CI)c
Unadjusted

Adjustedd

Other

1 [Reference]

1 [Reference]

Lower back

1.66 (1.43-1.92)

1.63 (1.38-1.93)

Finger(s)

0.43 (0.33-0.57)

0.62 (0.46-0.84)e

Urban

1 [Reference]

1 [Reference]

Rural

0.71 (0.63-0.80)

1.51 (1.31-1.73)

<5

1 [Reference]

1 [Reference]

5-9

1.75 (1.51-2.03)

1.83 (1.56-2.14)

10-19

3.80 (3.20-4.50)

4.73 (3.90-5.75)

≥20

14.00 (11.89-16.48)

28.94 (23.44-35.72)

Long-acting opioid within 30 d of injury

17.06 (13.16-22.11)

3.01 (2.16-4.20)

Overlapping opioid and benzodiazepine
prescription days within 30 d of injury

3.80 (3.17-4.55)

1.38 (1.10-1.72)e

1

1 [Reference]

1 [Reference]

2

5.25 (4.48-6.15)

4.28 (3.55-5.17)

≥3

22.76 (19.55-26.51)

14.91 (12.15-18.29)

1 [Reference]

1 [Reference]

Abbreviations: MME, morphine milligram equivalents;
OR, odds ratio.

2

5.62 (4.93-6.41)

1.89 (1.60-2.21)

a

≥3

18.82 (16.00-22.15)

4.54 (3.70-5.56)

Long-term opioid use was defined as receiving an
opioid on most days in the 90 days after injury.

b

Results from unconditional logistic regression
analyses for derivation model (C statistic, 0.92).

Characteristic
Part of body injured

Residence type

Initial days’ supply

No. of prescribers visited for opioids within
90 d of injury

No. of pharmacies visited for opioids within
90 d of injury
1

Maximum MME received within 30 d of
injury
<40

1 [Reference]

1 [Reference]

c

P < .001 unless otherwise noted.

40-159

2.69 (2.39-3.01)

1.67 (1.45-1.92)

d

Adjusted for all variables in this Table.

≥160

8.18 (5.77-11.61)

3.24 (2.12-4.95)

e

P < .01.
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and pharmacies, except that the OR for an initial supply of 20 or fewer days decreased and the OR for
amount of MME increased (eTable 4 in the Supplement).
Risk factors shown to be associated with opioid receipt in a previous study of this cohort12 were
also evaluated for their association with long-term use. When the model was restricted to people
with fractures, the model fit was lowered to a C statistic of 0.87, and the association of receiving 20
or fewer days’ initial supply decreased (adjusted OR, 6.30; 95% CI 3.84-10.18) but was still significant,
while lower back injuries and overlapping opioid and benzodiazepine prescriptions were no longer
significant (eTable 2 in the Supplement). Restricting the model to the most common injury (ie,
strains, sprains, and tears) lowered the model fit to a C statistic of 0.91, while associations were
unchanged except that finger injuries and MME of 160 or more were no longer significantly
associated with long-term opioid use (eTable 3 in the Supplement). Hydrocodone and oxycodone
were the most commonly prescribed opioids in both injury types and long-term use statuses
(eTable 5 in the Supplement).
Dose escalation was observed in 431 patients (23.5%) who began long-term opioid use. The
mean (SD; range) increase between the first and third months after injury was 34.04 (45.23; 0.221171.43) daily MME. Among injured workers who experienced dose escalation, 404 (69.4%)
increased by more than 10 daily MME over 3 months, and 79 (13.6%) surpassed the Tennessee
chronic pain guidelines threshold of 120 daily MMEs during this time. Among injured workers who
qualified as having long-term use in the first 90 days after injury, 557 patients (31.5%) were still using
opioids on most days 6 months after injury.

Discussion
In this study, 6 opioid-use characteristics (days’ supply of first prescription, receipt of a long-acting
opioid within 30 days of injury, overlapping opioid and benzodiazepine prescription, number of
prescribers and pharmacies visited within 90 days of injury, and maximum MME received within 30
days of injury) were associated with long-term opioid use in previously opioid-free injured workers.
The strongest association was receiving 20 or more days’ supply in the initial prescription, followed
by visiting 3 or more prescribers for opioids, associations which have been found in other
populations.22 Characteristics of opioid prescriptions, especially the initial prescription, had a greater
association with long-term use than patient demographic or injury characteristics.
A previous study of this cohort12 estimated that the prevalence of receiving an opioid after
injury was 22.8% within 1 week, 29.7% within 1 month, and 33.3% within 6 months. In this study,
most workers (79.6%) who received opioids after injury were opioid free before injury, and 4.0% of
these became long-term users. Notably, one-third of patients who qualified as long-term opioid users
in the 90 days after injury continued to use opioids 180 days after injury. Although dose escalation
was noted in only one-quarter of long-term users, it can contribute to opioid-related harms, and
surpassing 50 MME per day can increase the risk of overdose by 30%.10 Since Tennessee law
designates 30 days’ supply as the maximum that can be dispensed,23 opioid users had to have
received at least 2 opioid prescriptions over at least 2 months to surpass 45 prescription days and
meet the definition of a long-term user.
Although prescribing patterns were the strongest factors associated with long-term opioid use,
this study also identified associations of part of body injured and rural residence. Whereas other
studies have shown mixed associations of sex with long-term opioid use,17,18 no association of sex
was found in this study. Like a 2018 study of WC claimants in Maryland,5 this study found an
association of age with opioid use in bivariable analyses, but the inclusion of age decreased the
performance of the predictive model. Other studies have shown mixed associations of age with longterm opioid use.17,18,24 Like the Maryland study,5 this study found a positive association of strains,
sprains, and tears with long-term use. However, this study used a larger population (all injured
workers vs only those who received WC medical care), focused on prescribing rather than patient
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characteristics, and measured more opioid prescriptions (all dispensed prescriptions vs only those
paid for by employers’ insurance) in defining long-term use.
Addressing injury as a gateway to long-term opioid use is an important step toward curbing the
opioid epidemic.25 Although previous studies have identified risk factors for the development of
long-term opioid use, this appears to be the first to comprehensively measure all opioid
prescriptions, regardless of insurance type, opioid dependence, or substance use disorder diagnosis,
for long-term use in injured workers. In this predictive model, prescribing practices appear to be
more associated with opioid use than demographic characteristics. Unlike patient demographic
characteristics, prescribing may be modified to reduce patient risk.26,27

Limitations
This study has limitations. Owing to unavailability of clinical data, this study was not able to consider
several major factors associated with opioid use disorders, including genetic predisposition, mental
illness, other drug use, race/ethnicity, and surgery status.28 However, our study provides an approach
for using existing public health data sources to identify important factors associated with long-term
opioid use in unique populations. Further, owing to a healthy worker effect where ill workers are
excluded from employment, mental illness and other drug use may not cause much confounding in
the model.29
Lack of data on comorbidities may also account for some of the differences seen in the model
when the number of prescribers and dispensers visited were excluded. The number of contacts with
medical care could indicate multiple health conditions, and medical comorbidities have been
associated with long-term opioid use in other studies.18 Multiple contacts may also be an indication
of drug-seeking behavior among people with an opioid use problem.30 Patient reports or flags in the
CSMD about visiting multiple prescribers and pharmacies can still serve as a warning sign of potential
long-term use.
The effect of race and ethnicity may be a larger concern; studies in other states show that white
patients tend to be prescribed opioids more frequently31 and are more likely to overdose on opioids
than black patients,32 but nonwhite workers are more likely to receive WC.33 Stratifying by race/
ethnicity may provide more granular detail toward understanding the trends in the epidemic and
directing resources toward groups that would benefit from increased attention. It may also decrease
the association of residence type with opioid use, as white residents are more concentrated in rural
areas of Tennessee.25 Although not all potential factors associated with long-term opioid use could
be assessed, the variables included in this study resulted in a predictive model with extraordinarily
good fit.
This study provides a good picture of the development of long-term opioid use in previously
opioid-free injured workers in Tennessee but may not be generalizable to injured workers who do not
report injuries to WC, report more than 1 injury, or live and work in other areas. Additionally, this study
measures only prescriptions that were filled legally in Tennessee and may have missed prescriptions
that were not consumed or were obtained from other sources. Misclassification of opioid-free
patients owing to opioid supply from nonlegal sources or sources not measured by the CSMD is
possible.

Conclusions
To our knowledge, this was the first study to examine long-term opioid use in Tennessee and among
the first nationally to use a prescription drug monitoring program to measure long-term opioid use
in injured workers with prescription records instead of clinical or insurance records. Developing longterm use appears to be more associated with prescribing practices, especially days’ supply of the
initial prescription, than patient or injury characteristics. These practices can be modified to reduce
patient risk of overdose and associated morbidities.
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